India CDSCO Amends Sterilization Rules: What Removing the Loan Licence Means for Medical Devices

India's CDSCO has amended the Medical Devices Rules, 2017, effective August 24, 2024, removing the 'loan licence' requirement for manufacturers who outsource device sterilization. This episode explains the amendment, details the new mandatory labeling requirements for sterilized products, and outlines the practical steps that regulatory and quality teams must take during the six-month transition period to ensure compliance. Key Questions: - What was the 'loan licence' requirement for medical device sterilization in India? - How does the CDSCO's August 2024 amendment change the rules for outsourced sterilization? - Who is most affected by this regulatory update? - What are the new, specific labeling requirements for sterile medical devices? - What is the deadline for manufacturers to comply with these new labeling rules? - How does this change impact the relationship between manufacturers and third-party sterilization facilities? - What practical steps should regulatory teams take to ensure compliance? - Does this amendment simplify the market access process in India? Sources: - https://www.livemint.com/industry/pharma/govt-eases-medical-device-rules-speeds-access-to-eu-approved-products-11724508681177.html How Pure Global can help: Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access. For companies navigating changes like India's new sterilization rules, we provide expert regulatory strategy, technical dossier preparation, and local representation in over 30 markets. Our team helps ensure your labeling, QMS, and supplier agreements are fully compliant, minimizing delays and risks. Leverage our advanced AI tools and data-driven insights to manage submissions efficiently and maintain your market presence. Contact us at [email protected] or visit https://pureglobal.com. Explore our free AI tools and database at https://pureglobal.ai.